MRTs are characterized by the biallelic inactivation of the SMARCB1 (INI1/SNF5/BAF47) gene, which encodes a core component of the SWI/SNF complex and is a tumor suppressor (Kim and Roberts, 2014). This evidence concerns the gene SMARCB1 and neoplasm.